Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    OA06 - Prognostic & Predictive Biomarkers

    • Type: Oral Session
    • Track: Biology/Pathology
    • Presentations: 8
    • Moderators:F. Shepherd
    • Coordinates: 12/05/2016, 14:20 - 15:50, Strauss 1
  • +

    P2.06 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Scientific Co-Operation/Research Groups (Clinical Trials in Progress should be submitted in this category)
    • Presentations: 47
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.06-022 - First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study

      14:30 - 14:30  |  Author(s): T. Mok

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PL04a - Plenary Session: Immune Checkpoint Inhibitors in Advanced NSCLC

    • Type: Plenary
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:J. Soria
    • Coordinates: 12/07/2016, 08:45 - 09:40, Hall D (Plenary Hall)
    • +

      PL04a.01 - Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024 (Abstract under Embargo until December 7, 7:00 CET)

      08:45 - 08:55  |  Author(s): J.R. Brahmer

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.01 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Biology/Pathology
    • Presentations: 64
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.01-034 - Migration and Epithelial to Mesenchymal Transition of Lung Cancer Can Be Targeted via Translation Initiation Factors eIF4E and eIF4GI

      14:30 - 14:30  |  Author(s): O. Attar-Schneider

      • Abstract

      Loading...

  • +

    P3.02c - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 103
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02c-030 - Use of a 200-Mg Fixed Dose of Pembrolizumab for the Treatment of Advanced Non–Small Cell Lung Cancer (NSCLC)

      14:30 - 14:30  |  Author(s): E.B. Garon

      • Abstract

      Loading...